}

LVP PHARMA ups stake in Rameda to 31.5%

Updated 6/10/2026 9:24:00 AM
LVP PHARMA ups stake in Rameda to 31.5%

Arab Finance: LVP PHARMA has purchased 166.965 million shares in Tenth of Ramadan Pharmaceutical Industries and Diagnostic Reagents Company (Rameda) at a value of EGP 846.513 million, or an average price of EGP 5.07 per share, according to a bourse filing.

Hence, the company increased its shareholding in Rameda to 31.498% from 23.15%.

Al Ahly Pharos Securities Brokerage handled the transaction, which was executed on June 8th.

In February, LVP PHARMA raised its stake in the EGX-listed company to 11.767% from 9.22%.

Related News